← All stocks

AN2 Therapeutics, Inc.

ANTX Mostly scheduled

CIK 0001880438 #3872 in the set updated 17 Sep 2026

Bought (1 mo)

$11.60K

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$318.20K

$316.70K on a plan · $0.00 straight out of an exercise

Sold at will

$1.50K

1 of 9 sales

Net

−$306.60K

+$10.10K against sales at will

By person

14 insiders · 10 transactions

14.3×

Eric Easom holds 14.3 times base salary in stock. $8.64M of shares against $603.75K in salary for 2025.

Salary from the company's own proxy. The shares are what Eric Easom last reported holding, valued at $6.02, the price Common Stock was last bought or sold at on the open market here, on 9 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Readnour Robin Shane

Director

—

$316.70K (8) scheduled

−$316.70K

1,267,709

3.36%

$7.64M

+29.9%

FitzPatrick Margaret M

Director

$11.60K (1)

—

+$11.60K

10,708

0.0284%

$64.51K

—

Williams Sarah Joanne

Principal Accounting Officer

—

$1.50K (1)

−$1.50K

66,311

0.1757%

$399.48K

+252.7%

Leonard Braden Michael

10% owner

—

3,217,432

8.53%

$19.38M

−45.9%

Easom Eric

Chief Executive Officer

—

1,434,396

3.80%

$8.64M

+28.4%

Eizen Joshua M

See Remarks

—

206,554

0.5474%

$1.24M

+88.1%

Zakrzewski Joseph S

Director

—

145,538

0.3857%

$876.76K

−71.1%

Chanda Sanjay

Chief Development Officer

—

118,823

0.3149%

$715.83K

+177.7%

Day Lucy

Chief Financial Officer

—

118,363

0.3137%

$713.05K

+159.4%

Trenor Cameron C. III

Chief Medical Officer

—

116,667

0.3092%

$702.84K

—

Marks Gilbert Lynn

Director

—

81,873

0.2170%

$493.23K

+258.6%

Aziz Kabeer

Director

—

59,106

0.1566%

$356.07K

—

Prior Stephen David

Chief Strategy Officer

—

59,086

0.1566%

$355.95K

+95.5%

Martin Patricia A.

Director

—

18,863

0.0500%

$113.64K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Readnour Robin Shane

9 Sep 2026

Director

Sold on a plan indirect

585

$6.02

$3.52K

Readnour Robin Shane

9 Sep 2026

Director

Sold on a plan indirect

523

$6.02

$3.15K

Readnour Robin Shane

8 Sep 2026

Director

Sold on a plan indirect

5,294

$6.02

$31.86K

Readnour Robin Shane

8 Sep 2026

Director

Sold on a plan indirect

4,725

$6.02

$28.44K

Readnour Robin Shane

3 Sep 2026

Director

Sold on a plan indirect

3,223

$6.07

$19.56K

Readnour Robin Shane

3 Sep 2026

Director

Sold on a plan indirect

2,877

$6.07

$17.46K

Readnour Robin Shane

17 Aug 2026

Director

Sold on a plan indirect

18,706

$6.01

$112.39K

Readnour Robin Shane

17 Aug 2026

Director

Sold on a plan indirect

16,696

$6.01

$100.31K

Show all 10 transactions →

AN2 Therapeutics, Inc.

By person

Individual transactions

What was left out